DEA Registers 900+ Medical Cannabis Dispensaries in a Federal First, but Bars Dual-Licensing States Like Minnesota

On Friday, October 30, 2026, the U.S. Drug Enforcement Administration issued federal registrations to more than 900 state-licensed medical cannabis dispensaries, the first time the agency has ever registered marijuana businesses, approving operators in seven states: Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia, according to a Justice Department news release reported by WXXV News 25 via the AP wire. The registrations follow Attorney General Todd Blanche's April 2026 order moving state-licensed medical marijuana from Schedule I to Schedule III, a change Blanche said "will help ensure broader access to chronic pain treatment and the safety of the American people." At the same time, Marijuana Moment reported that DEA refused registration to a Minnesota operator because that state's "dual-purpose marijuana license, permitting both medical and non-medical dispensing falls outside the recent promulgated definition of 'state medical license,'" a split that leaves businesses in roughly two dozen dual-licensing states outside the new federal framework. The department did not immediately identify the approved businesses, and nearly 7,000 other dispensaries, manufacturers and distributors have applied for registration, per a DEA list published Friday.

What happened

The registrations are the first concrete step of the rescheduling process set in motion by Attorney General Todd Blanche's April 2026 order, which moved state-licensed medical marijuana from Schedule I, the category for drugs with "no medical use" such as heroin, to Schedule III. Blanche said at the time that the change "largely legitimized medical marijuana programs in the 40 states that have adopted them," per the Justice Department release carried by WXXV News 25.

The money angle is central: because state-licensed cannabis businesses sold a Schedule I drug, they historically could not deduct normal expenses such as advertising, rent and labor on federal taxes, a burden industry figures called "financially crippling." DEA registration is expected to unlock those deductions for registered businesses.

The refusal angle comes from order documents obtained by Marijuana Moment. DEA told Minneapolis operator In-Dispensary that Minnesota's dual medical and recreational licensing falls outside the federal definition of a "state medical license." The order to show cause was signed by Cheri Oz, assistant administrator of DEA's Diversion Control Division, who wrote that granting registration "would be inconsistent with the [Controlled Substances Act] as well as United States' treaty obligations." DEA also objected that Minnesota lets military veterans access medical marijuana "who merely submit their veteran identification and an attestation" instead of written doctor certifications, and that the state "permits dispensaries to dispense synthetic marijuana products," meaning hemp-derived cannabinoids. In-Dispensary has 30 days to request a hearing or file a corrective action plan.

All seven approved states are medical-only; Virginia passed adult-use legalization this year but has not yet initiated licensing. The Minnesota Office of Cannabis Management said the federal order "does not impact the state law that authorizes Minnesota's medical cannabis and adult-use cannabis programs."

Why it matters

The registrations mark the first federal recognition of marijuana businesses in U.S. history and carry immediate financial consequences. Registered businesses in the seven approved states stand to gain federal tax deductions long denied to the industry, while businesses in the two dozen states that license both medical and adult-use cannabis risk being shut out of those benefits and of the protections that come with rescheduling. The DEA's stated grounds for refusal, treaty obligations and the Controlled Substances Act, signal how the agency may treat the roughly 7,000 pending applications from dual-licensing states. The move also lands days before the 30th anniversary of California legalizing medical marijuana in November 1996, a milestone advocates cited in framing the registrations as the culmination of three decades of state-level expansion.

How it is being covered

According to ground.news, the story is carried by 56 sources with a left/centre/right split of 42/39/19 percent, and 45 of 56 outlets rate as high or very high factuality. Coverage is broad across the spectrum, with the tax-benefit angle prominent in wire-derived local reporting and the refusal documents driving the trade and advocacy press; no clear blindspot was flagged in the aggregate figures.

What to watch

• Whether In-Dispensary requests a hearing or files a corrective action plan within its 30-day window, and how DEA rules on the definition of a "state medical license."
• How DEA handles the roughly 7,000 pending applications, particularly from businesses in the 24 states plus D.C. that allow adult recreational use.
• Whether dual-licensing states adjust their programs, for example by separating medical licensing, to qualify businesses for registration and the associated federal tax deductions.
• The outcome of the DEA hearing process on broader rescheduling beyond medical cannabis, where testimony has concluded.
• Advocacy responses from groups such as Americans for Safe Access as the program takes shape.

Advocates' positions frame both sides of the story. Steph Sherer, founder of Americans for Safe Access, called the registrations "a tremendous victory for patient access and an opportunity to build on 30 years of progress." Chris Lindsey, VP of policy at the American Trade Association for Cannabis and Hemp, said: "It's obviously a positive step to see the program taking shape... What everybody's watching for is, what can we expect to see now that we have companies that are going to be operating in this class?"

By the numbers